CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
The Journal of Pathology, 08/17/2012
Grosse–Gehling P et al. – The authors highlight the link between the tumour microenvironment, tumour cell plasticity and CD133 expression, and evaluate the utility of CD133 expression as a prognostic marker.



